DOCSLIB.ORG

Finding the Causes of Inherited Neuropathies

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Finding the Causes of Inherited Neuropathies NEUROLOGICAL REVIEW SECTION EDITOR: DAVID E. PLEASURE, MD Finding the Causes of Inherited Neuropathies Steven S. Scherer, MD, PhD he genetic causes of inherited neuropathies and their classification are the topics of this review. The large number of disorders as well as cumbersome and even inconsis- tent nomenclature make this a daunting task. Owing to limited space, I will not elabo- rate on the clinical features or diagnostic approaches of these disorders, and the pri- Tmary literature is not referenced; these topics are more fully discussed elsewhere.1-4 In addition, much information can be found in Online Mendelian Inheritance in Man (OMIM) (http://www .ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM; the 6-digit OMIM numbers of various disorders are given in the text and in the Table), the Mutation Database of Inherited Peripheral Neuropa- thies (http://www.molgen.ua.ac.be/CMTMutations), and the Neuromuscular Disease Center of Wash- ington University (http://www.neuro.wustl.edu/neuromuscular). WHAT IS without segmental demyelination or CHARCOT-MARIE-TOOTH DISEASE? remyelination. These findings were ex- tended by several groups, including More than a century ago, Charcot, Marie, Harding and Thomas,5 who proposed that and Tooth described patients who, as we forearm motor conduction velocities of now understand it, have a dominantly in- 38 m/s separated CMT1 from CMT2 herited, progressive neuropathy that af- (Figure 1A), a heuristic aid that can be fects myelinated motor and sensory axons misleading if applied too rigidly. in a length-dependent manner. This dis- This classification underscored the idea order is usually called Charcot-Marie- that CMT1 might be caused by muta- Tooth disease (CMT). Soon thereafter, re- tions in genes that are expressed by my- cessive cases of more severely affected individuals (with Dejerine-Sottas neuropa- elinating Schwann cells whereas CMT2 thy [DSN]) as well as kindreds with X- might be caused by mutations in genes ex- linked CMT type 1 (CMT1X) were de- pressed by neurons. This possibility was scribed. Dyck and colleagues introduced first formally demonstrated by Aguayo et the currently used classification scheme, al,6 who grafted nerve segments from although they used the term hereditary mo- Trembler mice (which have a domi- tor and sensory neuropathy rather than nantly inherited demyelinating neuropa- CMT. They demonstrated that most kin- thy) into the sciatic nerves of normal mice. dreds had CMT1, characterized by slowed The host axons that regenerated into the motor conduction velocities (10-40 m/s) donor nerve grafts were abnormally my- in the arms and histological evidence of elinated by the donor Schwann cells, segmental demyelination and remyelin- thereby demonstrating that the demyelin- ation in addition to axonal loss. The CMT2 ation defect was intrinsic to the Schwann kindreds tended to have a later age at on- cells. This concept is supported by the set, little if any slowing of nerve conduc- demonstration that myelinating Schwann tions, and loss of myelinated axons but cells or neurons express the genes that cause demyelinating or axonal neuropa- Author Affiliation: University of Pennsylvania Medical School, Philadelphia. thies, respectively. (REPRINTED) ARCH NEUROL / VOL 63, JUNE 2006 WWW.ARCHNEUROL.COM 812 Downloaded from www.archneurol.com at University of Pennsylvania, on June 13, 2006 ©2006 American Medical Association. All rights reserved. Table. Genetics of Nonsyndromic Inherited Neuropathies A Dominantly Inherited Neuropathies Disease (OMIM No.) Linkage or Gene Motor Sensory CMT1, autosomal or X-linked dominant demyelinating HNPP (162500) PMP22 CMT1 HMSN I CMT1A (118220) PMP22 Demyelinating Demyelinating CMT1B (118200) MPZ Axonal Axonal CMT1C (601098) LITAF/SIMPLE HMSN II CMT1D (607687) EGR2 CMT2 CMT1X (302800) GJB1 DI-CMT DI-CMTA (606483) 10q24.1-25.1 DI-CMTB (696482) DNM2 DI-CMTC (608323) YARS CMT2, autosomal dominant axonal or neuronal B Inherited Demyelinating Diseases CMT2A1 (118210) KIF1B CMT2A2 (609260) MFS2 Motor Sensory CMT2B (600882) RAB7 CMT2C (606071) 12q23-24 CMT2D (601472) GARS CMT1 CMT2E (162280) NEFL CMT 4 CMT2F (606595) HSPB1 Metachromatic and Globoid-Cell LD CMT2G (608591) 12q12-q13.3 Waardenburg IV Syndrome CMT2 (604484) 3q13.1 Cockayne Syndrome CMT2-P0 (118200) MPZ CMT2L (608673) HSPB8 Syndromic CMT4, AR demyelinating neuropathy CMT4A (214400) GDAP1 CMT4B-1 (601382) MTMR2 Pelizaeus-Merzbacher Disease CMT4B-2 (604563) MTMR13 Pelizaeus-Merzbacher–like Disease CMT4C (601596) KIAA1985 CMT4D (601455) NDRG1 CMT4F (605260) PRX Nonsyndromic Nonsyndromic CNS HMSN-R (605285) 10q23.2 CMT4H (609311) 12p11.21-q13.11 CMT4 (605253) EGR2 AR-CMT2, AR axonal neuropathy C Inherited Axonal or Neuronal Diseases or CMT2B AR-CMT2A (605588) LMNA Motor Sensory AR-CMT2B (605589) 19q13.1-13.3 CMT2K (607831) GDAP1 Hereditary Hereditary Congenital AR axonal neuropathy 5q deletion Motor CMT2 Sensory HSAN Neuropathy AR-CMT 2 Neuropathy HSAN1 (162400) SPTLC1; dominant HSAN1B (608088) 3p22-24; dominant Complicated SPG HSAN2 (201300) HSN2; recessive GAN HSAN3 (223900) IKBKAP; recessive NAD HSAN4 (256800) TRKA; recessive ALS4 HSAN5 (162030) NGFB; recessive Syndromic SPG17 Ataxias Primary erythermalgia (133020) SCN9A; dominant Cold-induced sweating (272430) CRLF1; recessive Pure SPG HMN HMN I (606595) Dominant HMN II (158590) HSPB8; dominant HMN II (608634) HSPB1; dominant Nonsyndromic Nonsyndromic CNS HMN III (607088) 11q13; recessive HMN IV Recessive HMN V (600794) GARS, dominant; BSCL2, dominant Figure 1. The relationships of inherited neuropathies to each other and other HMN VI/SMARD1 (604320) IGHMBP2; recessive syndromes. These Venn diagrams depict that dominantly inherited HMN VII (158580) DCTN1 neuropathies can be separated into demyelinating and axonal forms (A); that HMN/ALS4 (602433) SETX; dominant inherited demyelinating diseases can be separated into those that cause Congenital distal SMA (600175) 12q23-q24; dominant peripheral nervous system and/or central nervous system (CNS) HMN Jerash (605726) 9p21.1-p12; recessive dysmyelination or demyelination (B); and that inherited axonal diseases can be separated into those that cause combinations of a motor neuropathy, Abbreviations: ALS4, amyotrophic lateral sclerosis type 4; AR, autosomal sensory neuropathy, or both sensory and motor neuropathy, each of which recessive; CMT, Charcot-Marie-Tooth disease; DI, dominant intermediate; may also involve CNS axons. CMT indicates Charcot-Marie-Tooth disease; HMN, hereditary motor neuropathy; HMSN, hereditary motor and sensory HMSN, hereditary motor and sensory neuropathy; LD, leukodystrophy; neuropathy; HNPP, hereditary neuropathy with liability to pressure palsies; AR, autosomal recessive; SPG, spastic paraplegia; GAN, giant axonal HSAN, hereditary sensory and autonomic neuropathy; OMIM, Online neuropathy; ALS, amyotrophic lateral sclerosis; and NAD, neuroaxonal Mendelian Inheritance in Man; SMA, spinal muscular atrophy; dystrophy. SMARD1, spinal muscular atrophy with respiratory distress type 1. (REPRINTED) ARCH NEUROL / VOL 63, JUNE 2006 WWW.ARCHNEUROL.COM 813 Downloaded from www.archneurol.com at University of Pennsylvania, on June 13, 2006 ©2006 American Medical Association. All rights reserved. DOMINANT KINDS OF CMT fundamental disturbance caused by DNM2 mutations af- fects neurons or axons, Schwann cells, or both. Mapping the genetic loci of different kindreds led to the identification of the causative genetic defects and the re- RECESSIVE KINDS OF CMT alization that multiple genes cause CMT1, CMT2, and DSN. This began with the discovery that the PMP22 gene Recessive types of CMT are less common than domi- (which encodes an intrinsic membrane protein of com- nantly inherited neuropathies and are mainly caused by pact myelin, peripheral myelin protein 22) is duplicated mutations in a different group of genes (Table). The de- in CMT1A and deleted in hereditary neuropathy with li- myelinating forms (CMT4) are caused by mutations in ability to pressure palsies. Mutations in genes already MTMR2 or MTMR13 (which likely interact to form a phos- known to be expressed by myelinating Schwann cells were phatase), EGR2, PRX (which encodes periaxin, part of a found to cause other kinds of dominantly inherited de- dystroglycan complex), and NDRG1 or KIAA1985 (which myelinating neuropathies—myelin protein zero (MPZ), encode proteins of unknown function). Myelinating which encodes the major adhesive protein of compact Schwann cells express all of these genes, and the avail- myelin, and EGR2, which encodes a transcription fac- able data indicate that each of the corresponding pro- tor. Charcot-Marie-Tooth disease type 1 was also found teins likely has an essential role in Schwann cells so that to be caused by mutations in genes not previously known recessive mutations result in demyelination. Although re- to be expressed by myelinating Schwann cells—GJB1, cessive GDAP1 mutations cause a neuropathy with some which encodes the gap junction protein connexin32, and demyelinating features, the neuropathy appears to be axo- LITAF/SIMPLE, which encodes a protein that may be in- nal in other kindreds. The basis of this discrepancy re- volved in the degradation of intracellular proteins. mains to be determined. Charcot-Marie-Tooth disease type 2 is less common Besides GDAP1, pure recessively inherited axonal neu- than CMT1, and it also results from diverse genetic causes. ropathies are rare.7 Recessive mutations in LMNA (which A dominant mutation in KIF1B, which encodes a kine- encodes lamin A/C) cause
Load more

Recommended publications
  • Targeted Genes and Methodology Details for Neuromuscular Genetic Panels
    Targeted Genes and Methodology Details for Neuromuscular Genetic Panels Reference transcripts based on build GRCh37 (hg19) interrogated by Neuromuscular Genetic Panels Next-generation sequencing (NGS) and/or Sanger sequencing is performed Motor Neuron Disease Panel to test for the presence of a mutation in these genes. Gene GenBank Accession Number Regions of homology, high GC-rich content, and repetitive sequences may ALS2 NM_020919 not provide accurate sequence. Therefore, all reported alterations detected ANG NM_001145 by NGS are confirmed by an independent reference method based on laboratory developed criteria. However, this does not rule out the possibility CHMP2B NM_014043 of a false-negative result in these regions. ERBB4 NM_005235 Sanger sequencing is used to confirm alterations detected by NGS when FIG4 NM_014845 appropriate.(Unpublished Mayo method) FUS NM_004960 HNRNPA1 NM_031157 OPTN NM_021980 PFN1 NM_005022 SETX NM_015046 SIGMAR1 NM_005866 SOD1 NM_000454 SQSTM1 NM_003900 TARDBP NM_007375 UBQLN2 NM_013444 VAPB NM_004738 VCP NM_007126 ©2018 Mayo Foundation for Medical Education and Research Page 1 of 14 MC4091-83rev1018 Muscular Dystrophy Panel Muscular Dystrophy Panel Gene GenBank Accession Number Gene GenBank Accession Number ACTA1 NM_001100 LMNA NM_170707 ANO5 NM_213599 LPIN1 NM_145693 B3GALNT2 NM_152490 MATR3 NM_199189 B4GAT1 NM_006876 MYH2 NM_017534 BAG3 NM_004281 MYH7 NM_000257 BIN1 NM_139343 MYOT NM_006790 BVES NM_007073 NEB NM_004543 CAPN3 NM_000070 PLEC NM_000445 CAV3 NM_033337 POMGNT1 NM_017739 CAVIN1 NM_012232 POMGNT2
    [Show full text]
  • Defining Functional Interactions During Biogenesis of Epithelial Junctions
    ARTICLE Received 11 Dec 2015 | Accepted 13 Oct 2016 | Published 6 Dec 2016 | Updated 5 Jan 2017 DOI: 10.1038/ncomms13542 OPEN Defining functional interactions during biogenesis of epithelial junctions J.C. Erasmus1,*, S. Bruche1,*,w, L. Pizarro1,2,*, N. Maimari1,3,*, T. Poggioli1,w, C. Tomlinson4,J.Lees5, I. Zalivina1,w, A. Wheeler1,w, A. Alberts6, A. Russo2 & V.M.M. Braga1 In spite of extensive recent progress, a comprehensive understanding of how actin cytoskeleton remodelling supports stable junctions remains to be established. Here we design a platform that integrates actin functions with optimized phenotypic clustering and identify new cytoskeletal proteins, their functional hierarchy and pathways that modulate E-cadherin adhesion. Depletion of EEF1A, an actin bundling protein, increases E-cadherin levels at junctions without a corresponding reinforcement of cell–cell contacts. This unexpected result reflects a more dynamic and mobile junctional actin in EEF1A-depleted cells. A partner for EEF1A in cadherin contact maintenance is the formin DIAPH2, which interacts with EEF1A. In contrast, depletion of either the endocytic regulator TRIP10 or the Rho GTPase activator VAV2 reduces E-cadherin levels at junctions. TRIP10 binds to and requires VAV2 function for its junctional localization. Overall, we present new conceptual insights on junction stabilization, which integrate known and novel pathways with impact for epithelial morphogenesis, homeostasis and diseases. 1 National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK. 2 Computing Department, Imperial College London, London SW7 2AZ, UK. 3 Bioengineering Department, Faculty of Engineering, Imperial College London, London SW7 2AZ, UK. 4 Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Role of Non-Motile Microtubule-Associated Proteins in Virus Trafficking
    BioMol Concepts 2016; 7(5-6): 283–292 Review Débora M. Portilho, Roger Persson and Nathalie Arhel* Role of non-motile microtubule-associated proteins in virus trafficking DOI 10.1515/bmc-2016-0018 continuously switching between phases of growth and Received June 21, 2016; accepted November 4, 2016 shrinkage, referred to as dynamic instability (1). MTs are involved in a wide range of cellular functions, including Abstract: Viruses are entirely dependent on their ability cell morphology, division, motility, and organelle posi- to infect a host cell in order to replicate. To reach their site tioning, as well as in disease, such as neurodegenerative of replication as rapidly and efficiently as possible follow- disease, infection and immunity. Once the MT filaments ing cell entry, many have evolved elaborate mechanisms are formed by nucleation at the centrosome and elon- to hijack the cellular transport machinery to propel them- gated from the subunit pool, their stability and mechani- selves across the cytoplasm. Long-range movements have cal properties are often controlled by a set of proteins that been shown to involve motor proteins along microtubules bind along the polymer. These so-called microtubule- (MTs) and direct interactions between viral proteins and associated proteins (MAPs, not to be confused with mito- dynein and/or kinesin motors have been well described. gen-activated proteins) are essential for the regulation of Although less well-characterized, it is also becoming MT dynamics. increasingly clear that non-motile microtubule-associated Several types of MAPs have been identified in eukary- proteins (MAPs), including structural MAPs of the MAP1 otes, including MT motors, MT plus-end and minus-end and MAP2 families, and microtubule plus-end tracking tracking proteins (+ TIPs, − TIPs), centrosome-associated proteins (+ TIPs), can also promote viral trafficking in proteins and structural MAPs.
    [Show full text]
  • Mitoxplorer, a Visual Data Mining Platform To
    mitoXplorer, a visual data mining platform to systematically analyze and visualize mitochondrial expression dynamics and mutations Annie Yim, Prasanna Koti, Adrien Bonnard, Fabio Marchiano, Milena Dürrbaum, Cecilia Garcia-Perez, José Villaveces, Salma Gamal, Giovanni Cardone, Fabiana Perocchi, et al. To cite this version: Annie Yim, Prasanna Koti, Adrien Bonnard, Fabio Marchiano, Milena Dürrbaum, et al.. mitoXplorer, a visual data mining platform to systematically analyze and visualize mitochondrial expression dy- namics and mutations. Nucleic Acids Research, Oxford University Press, 2020, 10.1093/nar/gkz1128. hal-02394433 HAL Id: hal-02394433 https://hal-amu.archives-ouvertes.fr/hal-02394433 Submitted on 4 Dec 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License Nucleic Acids Research, 2019 1 doi: 10.1093/nar/gkz1128 Downloaded from https://academic.oup.com/nar/advance-article-abstract/doi/10.1093/nar/gkz1128/5651332 by Bibliothèque de l'université la Méditerranée user on 04 December 2019 mitoXplorer, a visual data mining platform to systematically analyze and visualize mitochondrial expression dynamics and mutations Annie Yim1,†, Prasanna Koti1,†, Adrien Bonnard2, Fabio Marchiano3, Milena Durrbaum¨ 1, Cecilia Garcia-Perez4, Jose Villaveces1, Salma Gamal1, Giovanni Cardone1, Fabiana Perocchi4, Zuzana Storchova1,5 and Bianca H.
    [Show full text]
  • A Curated Gene List for Reporting Results of Newborn Genomic Sequencing
    © American College of Medical Genetics and Genomics ORIGINAL RESEARCH ARTICLE A curated gene list for reporting results of newborn genomic sequencing Ozge Ceyhan-Birsoy, PhD1,2,3, Kalotina Machini, PhD1,2,3, Matthew S. Lebo, PhD1,2,3, Tim W. Yu, MD3,4,5, Pankaj B. Agrawal, MD, MMSC3,4,6, Richard B. Parad, MD, MPH3,7, Ingrid A. Holm, MD, MPH3,4, Amy McGuire, PhD8, Robert C. Green, MD, MPH3,9,10, Alan H. Beggs, PhD3,4, Heidi L. Rehm, PhD1,2,3,10; for the BabySeq Project Purpose: Genomic sequencing (GS) for newborns may enable detec- of newborn GS (nGS), and used our curated list for the first 15 new- tion of conditions for which early knowledge can improve health out- borns sequenced in this project. comes. One of the major challenges hindering its broader application Results: Here, we present our curated list for 1,514 gene–disease is the time it takes to assess the clinical relevance of detected variants associations. Overall, 954 genes met our criteria for return in nGS. and the genes they impact so that disease risk is reported appropri- This reference list eliminated manual assessment for 41% of rare vari- ately. ants identified in 15 newborns. Methods: To facilitate rapid interpretation of GS results in new- Conclusion: Our list provides a resource that can assist in guiding borns, we curated a catalog of genes with putative pediatric relevance the interpretive scope of clinical GS for newborns and potentially for their validity based on the ClinGen clinical validity classification other populations. framework criteria, age of onset, penetrance, and mode of inheri- tance through systematic evaluation of published evidence.
    [Show full text]
  • Full Disclosure Forms
    Expanding genotype/phenotype of neuromuscular diseases by comprehensive target capture/NGS Xia Tian, PhD* ABSTRACT * Wen-Chen Liang, MD Objective: To establish and evaluate the effectiveness of a comprehensive next-generation * Yanming Feng, PhD sequencing (NGS) approach to simultaneously analyze all genes known to be responsible for Jing Wang, MD the most clinically and genetically heterogeneous neuromuscular diseases (NMDs) involving spi- Victor Wei Zhang, PhD nal motoneurons, neuromuscular junctions, nerves, and muscles. Chih-Hung Chou, MS Methods: All coding exons and at least 20 bp of flanking intronic sequences of 236 genes causing Hsien-Da Huang, PhD NMDs were enriched by using SeqCap EZ solution-based capture and enrichment method fol- Ching Wan Lam, PhD lowed by massively parallel sequencing on Illumina HiSeq2000. Ya-Yun Hsu, PhD ; 3 Thy-Sheng Lin, MD Results: The target gene capture/deep sequencing provides an average coverage of 1,000 per Wan-Tzu Chen, MS nucleotide. Thirty-five unrelated NMD families (38 patients) with clinical and/or muscle pathologic Lee-Jun Wong, PhD diagnoses but without identified causative genetic defects were analyzed. Deleterious mutations Yuh-Jyh Jong, MD were found in 29 families (83%). Definitive causative mutations were identified in 21 families (60%) and likely diagnoses were established in 8 families (23%). Six families were left without diagnosis due to uncertainty in phenotype/genotype correlation and/or unidentified causative Correspondence to genes. Using this comprehensive panel, we not only identified mutations in expected genes but Dr. Wong: also expanded phenotype/genotype among different subcategories of NMDs. [email protected] or Dr. Jong: Conclusions: Target gene capture/deep sequencing approach can greatly improve the genetic [email protected] diagnosis of NMDs.
    [Show full text]
  • A Master Autoantigen-Ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases
    bioRxiv preprint doi: https://doi.org/10.1101/2021.07.30.454526; this version posted August 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases Julia Y. Wang1*, Michael W. Roehrl1, Victor B. Roehrl1, and Michael H. Roehrl2* 1 Curandis, New York, USA 2 Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA * Correspondence: [email protected] or [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.07.30.454526; this version posted August 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract Chronic and debilitating autoimmune sequelae pose a grave concern for the post-COVID-19 pandemic era. Based on our discovery that the glycosaminoglycan dermatan sulfate (DS) displays peculiar affinity to apoptotic cells and autoantigens (autoAgs) and that DS-autoAg complexes cooperatively stimulate autoreactive B1 cell responses, we compiled a database of 751 candidate autoAgs from six human cell types. At least 657 of these have been found to be affected by SARS-CoV-2 infection based on currently available multi-omic COVID data, and at least 400 are confirmed targets of autoantibodies in a wide array of autoimmune diseases and cancer.
    [Show full text]
  • Analysis of Gene Expression in the Nervous System Identifies Key Genes and Novel Candidates for Health and Disease
    Neurogenetics (2017) 18:81–95 DOI 10.1007/s10048-017-0509-5 ORIGINAL ARTICLE Analysis of gene expression in the nervous system identifies key genes and novel candidates for health and disease Sarah M Carpanini1 & Thomas M Wishart1 & Thomas H Gillingwater2 & Jean C Manson1 & Kim M Summers1 Received: 13 July 2016 /Accepted: 20 January 2017 /Published online: 11 February 2017 # The Author(s) 2017. This article is published with open access at Springerlink.com Abstract The incidence of neurodegenerative diseases in the pathways and gene ontology term annotation. Additionally a developed world has risen over the last century, concomitant number of poorly annotated genes were implicated by this with an increase in average human lifespan. A major chal- approach in nervous system function. Exploiting gene expres- lenge is therefore to identify genes that control neuronal health sion data available in the public domain allowed us to validate and viability with a view to enhancing neuronal health during key nervous system genes and, importantly, to identify additional ageing and reducing the burden of neurodegeneration. genes with minimal functional annotation but with the same Analysis of gene expression data has recently been used to expression pattern. These genes are thus novel candidates for infer gene functions for a range of tissues from co-expression a role in neurological health and disease and could now be networks. We have now applied this approach to further investigated to confirm their function and regulation transcriptomic datasets from the mammalian nervous system during ageing and neurodegeneration. available in the public domain. We have defined the genes critical for influencing neuronal health and disease in different Keywords Mice .
    [Show full text]
  • Inappropriate Expression of the Translation Elongation Factor 1A Disrupts Genome Stability and Metabolism Daniel J
    © 2016. Published by The Company of Biologists Ltd | Journal of Cell Science (2016) 129, 4455-4465 doi:10.1242/jcs.192831 RESEARCH ARTICLE Inappropriate expression of the translation elongation factor 1A disrupts genome stability and metabolism Daniel J. Tarrant1, Mariarita Stirpe2, Michelle Rowe1, Mark J. Howard1, Tobias von der Haar1,* and Campbell W. Gourlay1,* ABSTRACT Thornton et al., 2003). However, despite its importance, the The translation elongation factor eEF1A is one of the most abundant mechanisms by which eEF1A participates in roles beyond proteins found within cells, and its role within protein synthesis is translation remain largely uncharacterised. Saccharomyces cerevisiae well documented. Levels of eEF1A are tightly controlled, with The yeast possesses two identical TEF1 TEF2 inappropriate expression linked to oncogenesis. However, the eEF1A-encoding genes and (Schirmaier and mechanisms by which increased eEF1A expression alters cell Philippsen, 1984). In contrast, eEF1A exists as two variant tissue- behaviour are unknown. Our analyses in yeast suggest that specific isoforms, eEF1A1 and eEF1A2, in all vertebrates. The first elevation of eEF1A levels leads to stabilisation of the spindle pole isoform, eEF1A1 is expressed in all tissues during development but body and changes in nuclear organisation. Elevation of the eEF1A2 is no longer detectable in the muscles and heart tissue of adults (Lee isoform also leads to altered nuclear morphology in cultured human et al., 1992; Chambers et al., 1998). Instead high-level expression of cells, suggesting a conserved role in maintaining genome stability. eEF1A2 is switched on in these tissues, as well as in motor neurons Gene expression and metabolomic analyses reveal that the level of of the medulla (Newbery et al., 2007).
    [Show full text]
  • 1 Proteins of the XMRV Retrovirus Implicated in Chronic Fatigue
    1 Proteins of the XMRV retrovirus implicated in chronic fatigue syndrome and prostate cancer are homologous to human proteins relevant to both conditions. C.J.Carter Flat 4, 20 Upper Maze Hill, Saint-Leonards on Sea , East Sussex, TN38 OLG [email protected] The XMRV retrovirus has been implicated in chronic fatigue syndrome and prostate cancer. A homology search comparing retroviral with human proteins revealed short contiguous amino acid strings (typically 5-8 aa) matching human proteins whose dysfunction might be expected to cause fatigue, including mitochondrial proteins related to oxidative phosphorylation, glutamate receptors and their synaptic scaffolds, muscular acetylcholine receptor scaffolds and structural proteins, components of the immune system, and phosphatidylinositol signalling inter alia. Viral proteins are also homologous to members of the oestrogen, peroxisome proliferator, and CREB activated receptor networks, all of which are implicated in prostate cancer, and to a protein, SRCAP, that controls the expression of the prostate- specific antigen. These short matches are often predicted to be antigenic, and antibodies to XMRV proteins may target their human homologues. This is supported by the presence of autoantibodies to muscarinic receptors , vimentin and LAMINB1 (all XMRV homologues) in chronic fatigue syndrome sufferers. Homologous XMRV proteins might also interfere with the protein interactomes of their human homologues. Viral mimicry of human proteins is extensive and often relevant to disease. For example Epstein-Barr viral proteins aligns with multiple sclerosis autoantigens, while HIV-1 proteins align with several components of the immune system. Mutant proteins in Huntington’s disease and cystic fibrosis also align with proteins from common phages or viruses.
    [Show full text]
  • UPF1: from Mrna Surveillance to Protein Quality Control
    biomedicines Review UPF1: From mRNA Surveillance to Protein Quality Control Hyun Jung Hwang 1,2, Yeonkyoung Park 1,2 and Yoon Ki Kim 1,2,* 1 Creative Research Initiatives Center for Molecular Biology of Translation, Korea University, Seoul 02841, Korea; [email protected] (H.J.H.); [email protected] (Y.P.) 2 Division of Life Sciences, Korea University, Seoul 02841, Korea * Correspondence: [email protected] Abstract: Selective recognition and removal of faulty transcripts and misfolded polypeptides are crucial for cell viability. In eukaryotic cells, nonsense-mediated mRNA decay (NMD) constitutes an mRNA surveillance pathway for sensing and degrading aberrant transcripts harboring premature termination codons (PTCs). NMD functions also as a post-transcriptional gene regulatory mechanism by downregulating naturally occurring mRNAs. As NMD is activated only after a ribosome reaches a PTC, PTC-containing mRNAs inevitably produce truncated and potentially misfolded polypeptides as byproducts. To cope with the emergence of misfolded polypeptides, eukaryotic cells have evolved sophisticated mechanisms such as chaperone-mediated protein refolding, rapid degradation of misfolded polypeptides through the ubiquitin–proteasome system, and sequestration of misfolded polypeptides to the aggresome for autophagy-mediated degradation. In this review, we discuss how UPF1, a key NMD factor, contributes to the selective removal of faulty transcripts via NMD at the molecular level. We then highlight recent advances on UPF1-mediated communication between mRNA surveillance and protein quality control. Keywords: nonsense-mediated mRNA decay; UPF1; aggresome; CTIF; mRNA surveillance; protein quality control Citation: Hwang, H.J.; Park, Y.; Kim, Y.K. UPF1: From mRNA Surveillance to Protein Quality Control. Biomedicines 2021, 9, 995.
    [Show full text]